Met Life Investment Management, LLC Insmed Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 89,622 shares of INSM stock, worth $5.94 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

89,622

Previous 89,570 0.06%

Holding current value

$5.94 Million

Previous $6 Million 9.02%

% of portfolio

0.04%

Previous 0.04%

51 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$62.0 - $79.01 $3,224 - $4,108	52 Added 0.06%	89,622 $6.54 Million
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $407,990 - $1.29 Million	18,545 Added 26.11%	89,570 $6 Million
Q1 2024 May 14, 2024	BUY	$25.72 - $29.94 $1.83 Million - $2.13 Million	71,025 New	71,025 $1.93 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $82,672 - $112,042	3,530 Added 5.12%	72,448 $2.25 Million
Q3 2023 May 09, 2024	SELL	$19.86 - $26.93 $38,151 - $51,732	-1,921 Reduced 2.71%	68,918 $1.74 Million
Q2 2023 Apr 29, 2024	BUY	$16.44 - $21.1 $1.13 Million - $1.45 Million	68,918 New	68,918 $1.45 Million
Q2 2023 Aug 10, 2023	SELL	$16.44 - $21.1 $31,581 - $40,533	-1,921 Reduced 2.71%	68,918 $1.45 Million
Q1 2023 May 09, 2024	BUY	$16.26 - $21.73 $1.15 Million - $1.54 Million	70,839 New	70,839 $1.21 Billion
Q4 2022 May 10, 2024	BUY	$16.98 - $23.15 $135,075 - $184,158	7,955 Added 12.65%	70,839 $1.42 Million
Q4 2022 Mar 22, 2023	BUY	$16.98 - $23.15 $135,075 - $184,158	7,955 Added 12.65%	70,839 $1.42 Million
Q4 2022 Feb 15, 2023	BUY	$16.98 - $23.15 $135,075 - $184,158	7,955 Added 12.65%	70,839 $1.42 Million
Q3 2022 Jun 14, 2023	SELL	$20.88 - $28.21 $166,100 - $224,410	-7,955 Reduced 11.23%	62,884 $1.35 Million
Q2 2022 Jun 20, 2023	SELL	$17.07 - $25.71 $135,791 - $204,523	-7,955 Reduced 11.23%	62,884 $1.24 Million
Q1 2022 May 10, 2024	BUY	$20.42 - $28.13 $1.28 Million - $1.77 Million	62,884 New	62,884 $1.48 Million
Q1 2022 Jun 20, 2023	SELL	$20.42 - $28.13 $162,441 - $223,774	-7,955 Reduced 11.23%	62,884 $1.48 Million
Q1 2022 Mar 22, 2023	BUY	$20.42 - $28.13 $466,209 - $642,236	22,831 Added 57.0%	62,884 $1.48 Million
Q1 2022 May 12, 2022	BUY	$20.42 - $28.13 $466,209 - $642,236	22,831 Added 57.0%	62,884 $1.48 Million
Q4 2021 Jun 21, 2023	SELL	$25.89 - $33.45 $797,049 - $1.03 Million	-30,786 Reduced 43.46%	40,053 $1.09 Million
Q3 2021 May 17, 2024	BUY	$22.46 - $29.47 $36,519 - $47,918	1,626 Added 4.23%	40,053 $1.1 Million
Q3 2021 Jun 21, 2023	SELL	$22.46 - $29.47 $691,453 - $907,263	-30,786 Reduced 43.46%	40,053 $1.1 Million
Q3 2021 Mar 22, 2023	BUY	$22.46 - $29.47 $36,519 - $47,918	1,626 Added 4.23%	40,053 $1.1 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $36,519 - $47,918	1,626 Added 4.23%	40,053 $1.1 Million
Q2 2021 Jun 21, 2023	SELL	$24.17 - $36.01 $783,398 - $1.17 Million	-32,412 Reduced 45.75%	38,427 $1.09 Million
Q1 2021 May 17, 2024	SELL	$32.28 - $44.3 $1.05 Million - $1.44 Million	-32,598 Reduced 45.9%	38,427 $1.31 Million
Q1 2021 Jun 26, 2023	SELL	$32.28 - $44.3 $1.05 Million - $1.44 Million	-32,412 Reduced 45.75%	38,427 $1.31 Billion
Q1 2021 Mar 22, 2023	SELL	$32.28 - $44.3 $109,622 - $150,442	-3,396 Reduced 8.12%	38,427 $1.31 Million
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $109,622 - $150,442	-3,396 Reduced 8.12%	38,427 $1.31 Million
Q4 2020 May 24, 2024	SELL	$31.45 - $40.54 $93,500 - $120,525	-2,973 Reduced 6.64%	41,823 $1.39 Million
Q4 2020 Jun 22, 2023	SELL	$31.45 - $40.54 $912,553 - $1.18 Million	-29,016 Reduced 40.96%	41,823 $1.39 Million
Q4 2020 Mar 22, 2023	SELL	$31.45 - $40.54 $93,500 - $120,525	-2,973 Reduced 6.64%	41,823 $1.39 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $93,500 - $120,525	-2,973 Reduced 6.64%	41,823 $1.39 Million
Q3 2020 Jun 26, 2023	SELL	$26.0 - $34.5 $677,118 - $898,483	-26,043 Reduced 36.76%	44,796 $1.44 Million
Q2 2020 May 24, 2024	SELL	$14.11 - $29.42 $370,091 - $771,657	-26,229 Reduced 36.93%	44,796 $1.23 Billion
Q2 2020 Jun 26, 2023	SELL	$14.11 - $29.42 $367,466 - $766,185	-26,043 Reduced 36.76%	44,796 $1.23 Million
Q2 2020 Mar 22, 2023	BUY	$14.11 - $29.42 $73,541 - $153,337	5,212 Added 13.17%	44,796 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $73,541 - $153,337	5,212 Added 13.17%	44,796 $1.23 Million
Q1 2020 Jul 12, 2023	SELL	$13.63 - $33.98 $426,005 - $1.06 Million	-31,255 Reduced 44.12%	39,584 $634,000
Q4 2019 Jul 12, 2023	SELL	$16.12 - $24.98 $503,830 - $780,749	-31,255 Reduced 44.12%	39,584 $945,000
Q3 2019 Jul 12, 2023	SELL	$15.49 - $25.78 $484,139 - $805,753	-31,255 Reduced 44.12%	39,584 $698,000
Q3 2019 Mar 22, 2023	BUY	$15.49 - $25.78 $98,376 - $163,728	6,351 Added 19.11%	39,584 $698,000
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $98,376 - $163,728	6,351 Added 19.11%	39,584 $698,000
Q2 2019 Jul 12, 2023	SELL	$23.0 - $32.19 $777,929 - $1.09 Million	-33,823 Reduced 47.75%	37,016 $947,000
Q1 2019 Jul 13, 2023	SELL	$13.91 - $31.15 $523,099 - $1.17 Million	-37,606 Reduced 53.09%	33,233 $966,000
Q4 2018 Jul 13, 2023	SELL	$11.6 - $18.7 $436,229 - $703,232	-37,606 Reduced 53.09%	33,233 $436,000
Q4 2018 Mar 22, 2023	SELL	$11.6 - $18.7 $227,012 - $365,959	-19,570 Reduced 37.06%	33,233 $436,000
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $227,012 - $365,959	-19,570 Reduced 37.06%	33,233 $436,000
Q3 2018 Jul 13, 2023	SELL	$18.95 - $28.08 $712,633 - $1.06 Million	-37,606 Reduced 53.09%	33,233 $671,000
Q3 2018 Mar 22, 2023	SELL	$18.95 - $28.08 $341,782 - $506,450	-18,036 Reduced 25.46%	52,803 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $287,111 - $425,440	15,151 Added 40.24%	52,803 $1.07 Million
Q2 2018 Aug 15, 2018	BUY	$20.0 - $29.72 $83,200 - $123,635	4,160 Added 12.42%	37,652 $890,000
Q4 2017 Feb 15, 2018	BUY	$26.43 - $31.78 $885,193 - $1.06 Million	33,492	33,492 $1.04 Million

Others Institutions Holding INSM

# of Institutions

465

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Insmed Inc Transaction History